| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $491.6M | +15.5% |
| Cost of Revenue | $193.1M | +19.3% |
| Gross Profit | $298.5M | +13.2% |
| R&D Expense | $41.9M | -4.9% |
| SG&A Expense | $121.7M | +13.7% |
| Operating Income | -$8.1M | -174.7% |
| Pre-tax Income | -$10.1M | -158.0% |
| Income Tax | $2.2M | +188.8% |
| Net Income | -$12.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.8M | +25.2% |
| Accounts Receivable | $102.9M | +33.7% |
| Current Assets | $241.2M | +23.3% |
| Total Assets | $719.2M | +7.3% |
| Current Liabilities | $403.2M | +9.2% |
| Long-term Debt | $49.06B | — |
| Total Liabilities | $489.5M | +11.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $76.8M | -16.4% |
| Capital Expenditures | $58.5M | +75.3% |
| Investing Cash Flow | -$85.0M | +71.3% |
| Financing Cash Flow | $17.1M | +287.9% |
| Free Cash Flow | $18.3M | -68.7% |
| -731.9% |
| Stockholders' Equity |
| $229.7M |
| -0.2% |